| # | Drug | Count |
|---|---|---|
| 0 | ERGOCALCIFEROL | 243 |
| 1 | CABOZANTINIB | 229 |
| 2 | OMEPRAZOLE MAGNESIUM | 192 |
| 3 | IBUPROFEN | 180 |
| 4 | ASPIRIN | 165 |
| 5 | OMEPRAZOLE | 160 |
| 6 | ACETAMINOPHEN | 158 |
| 7 | LEVOTHYROXINE SODIUM | 158 |
| 8 | ASPIRIN 325 MG | 152 |
| 9 | ASPIRIN 81 MG | 152 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 484 |
| 1 | Corticosteroid [EPC] | 351 |
| 2 | Benzodiazepine [EPC] | 261 |
| 3 | Proton Pump Inhibitor [EPC] | 197 |
| 4 | Kinase Inhibitor [EPC] | 184 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 170 |
| 6 | Vitamin C [EPC] | 157 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 135 |
| 8 | Dihydropyridine Calcium Channel Blocker [EPC] | 128 |
| 9 | Calcium Channel Blocker [EPC] | 117 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | APOC-III-directed RNA Interaction [EPC] | 1 | 0.0096 |
| 1 | Small Interfering RNA [EPC] | 1 | 0.0063 |
| 2 | Non-Standardized House Dust Allergenic Extract [EPC] | 2 | 0.0027 |
| 3 | Opioid Antagonist [EPC] | 2 | 0.0021 |
| 4 | Medium-chain Triglyceride [EPC] | 1 | 0.0018 |
| 5 | Anti-coagulant [EPC] | 6 | 0.0016 |
| 6 | Paramagnetic Contrast Agent [EPC] | 7 | 0.0015 |
| 7 | Cholinergic Nicotinic Agonist [EPC] | 90 | 0.0015 |
| 8 | Interleukin-17 Receptor A Antagonist [EPC] | 3 | 0.0015 |
| 9 | Dopamine-2 Receptor Antagonist [EPC] | 11 | 0.0014 |